We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells

News   Sep 10, 2020 | Original story from University of Washington

 
Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells

An artists' conception of how small synthetic proteins, built from scratch from computer designs, can have an antiviral effect by binding with Spike proteins on SARS-CoV-2. The binding interferes with the infectivity mechanism of the virus to try to keep it from latching onto and entering cells. Credit: UW Medicine Institute for Protein Design

 
 
Advertisement
 

RELATED ARTICLES

New Compound Traps the Malaria Parasite Inside Cells

News

Researchers have designed a drug-like compound that effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential malaria treatment.

READ MORE

New Molecule Could Enable Use of THC To Fight Pain Without the Side Effects

News

Researchers have developed a peptide that, in mice, allowed the main component of Cannabis sativa to fight chronic pain without impacting memory and other cognitive functions.

READ MORE

Innovative Approach for Ebola Vaccine Design

News

Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE